Lv76
3210 积分 2022-10-31 加入
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
2天前
已完结
Evaluation of regorafenib in colorectal cancer and GIST
4天前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
4天前
已完结
Regorafenib for metastatic colorectal cancer
4天前
已完结
Regorafenib, the CORRECT way forward or just another GRIDlock?
4天前
已完结
To be or not to be: The double-edged sword roles of liver progenitor cells
5天前
已完结
A decade of progress: advances in the third-line treatment of patients with metastatic colorectal cancer
29天前
已完结
Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases
1个月前
已完结
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
1个月前
已完结
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
1个月前
已完结
皖公网安备34019202002308
